Keywords: piolgitazone, cuts, bp, type, diabetics, results, large

Piolgitazone cuts BP in type 2 diabetics

Article | 14 June 2004

Results of a large, open-label, multicenter, observational clinical trial show that treatment with the oral anti-diabetic agent pioglitazone (Takeda's Actos) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Nystatin

Actos

Pioglitazone

Go to drug listing